Expression of TIM-3 was also detected on CD8+ T cells in myelodysplastic syndrome (MDS), demonstrating how this ligand is not exclusively involved in the exhaustion of immune cells committed to the recognition and elimination of solid tumors. This evidence concerns the gene HAVCR2 and myelodysplastic syndrome.